← Back to Search

Supervised walking on a treadmill for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by University of Arkansas, Fayetteville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights

Study Summary

This trial will study how well an exercise program improves cognition and brain health in people with type 2 diabetes, as well as how genetics may influence these effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Episodic memory
Executive function
Processing speed
+1 more
Secondary outcome measures
BMI
Fasting blood glucose in mg/dL
HbA1c in percentage
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Aerobic exercise groupExperimental Treatment1 Intervention
Group II: Attention control groupPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of Arkansas, FayettevilleLead Sponsor
20 Previous Clinical Trials
1,631 Total Patients Enrolled

Media Library

Supervised stretching exercise Clinical Trial Eligibility Overview. Trial Name: NCT04590833 — N/A
Type 2 Diabetes Research Study Groups: Attention control group, Aerobic exercise group
Type 2 Diabetes Clinical Trial 2023: Supervised stretching exercise Highlights & Side Effects. Trial Name: NCT04590833 — N/A
Supervised stretching exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04590833 — N/A
Type 2 Diabetes Patient Testimony for trial: Trial Name: NCT04590833 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollees still being welcomed into this trial?

"Affirmative. Clinicaltrials.gov data demonstrates that this research is currently recruiting volunteers, with the initial posting of it being on June 1st 2021 and its most recent edit on January 7th 2022. 84 individuals are required to be enrolled from a single site for this experiment."

Answered by AI

What key goals is this research aiming to achieve?

"This clinical trial will last for a period of 3 months, and the primary objective is to evaluate working memory. Secondary endpoints include fasting blood glucose (measured by YSI), weight in kilograms (health scale) and plasma BDNF levels (ELISA kit)."

Answered by AI

What is the aggregate assemblage of individuals involved in this experiment?

"That is correct. According to data found on clinicaltrials.gov, this experimental procedure was initially posted on June 1st 2021 and has most recently been updated January 7th 2022; 84 patients are sought from one location for the study's duration."

Answered by AI

Who else is applying?

What state do they live in?
Arkansas
What site did they apply to?
University of Arkansas
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

What questions have other patients asked about this trial?

How many times will I have to travel to Fayetteville for this study?
PatientReceived no prior treatments

Why did patients apply to this trial?

Cognitive decline is a new one to me! No one told me about this and it is scary.
PatientReceived no prior treatments
~22 spots leftby Apr 2025